Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.9K Buy
81
+76
+1,520% +$12.4K ﹤0.01% 212
2025
Q4
$975 Hold
5
﹤0.01% 247
2025
Q3
$1.41K Hold
5
﹤0.01% 270
2025
Q2
$1.09K Hold
5
﹤0.01% 300
2025
Q1
$700 Hold
5
﹤0.01% 310
2024
Q4
$834 Hold
5
﹤0.01% 317
2024
Q3
$852 Hold
5
﹤0.01% 323
2024
Q2
$706 Buy
+5
New +$621 ﹤0.01% 338
2015
Q2
$6.15M Buy
152,563
+5,328
+4% +$231K 1.05% 33
2015
Q1
$6.35M Sell
147,235
-200
-0.1% -$8.67K 1.16% 32
2014
Q4
$6.63M Sell
147,435
-3,050
-2% -$124K 1.19% 30
2014
Q3
$5.76M Sell
150,485
-3,100
-2% -$126K 1.09% 36
2014
Q2
$6.22M Buy
153,585
+19,385
+14% +$798K 1.1% 33
2014
Q1
$5.49M Sell
134,200
-18,050
-12% -$687K 1.02% 33
2013
Q4
$5.83M Sell
152,250
-2,600
-2% -$89.4K 1.11% 32
2013
Q3
$5.14M Sell
154,850
-2,800
-2% -$90.8K 1.03% 35
2013
Q2
$4.84M Buy
+157,650
New +$5.23M 1.02% 37

Other funds holding ORCL

Kimelman & Baird's ORCL Position: Q1 2026 in Review

Kimelman & Baird increased its Oracle (ORCL) stake by 1,520% in Q1 2026, buying an estimated $12.4K and bringing the position to 81 shares worth $11.9K. The position accounts for ﹤0.01% of the portfolio, ranked #212.

Kimelman & Baird first reported a position in ORCL in Q2 2013 and has held it in 17 quarters since. The position peaked at $6.63M in Q4 2014. 3,475 funds tracked by Wall St. Rank hold ORCL as of Q1 2026.

  • Kimelman & Baird held 81 shares of Oracle worth $11.9K as of Q1 2026.
  • Kimelman & Baird bought 76 Oracle shares in Q1 2026, an estimated $12.4K.
  • Oracle made up ﹤0.01% of Kimelman & Baird's portfolio in Q1 2026, its #212 holding.
  • Kimelman & Baird first reported a position in Oracle in Q2 2013 and has held it in 17 quarters since.
  • Kimelman & Baird's Oracle position peaked at $6.63M in Q4 2014.
  • 3,475 funds tracked by Wall St. Rank held Oracle as of Q1 2026.

Based on Kimelman & Baird's 13F filing for Q1 2026, filed 13 May 2026.